Dr. Carol Wilkinson, MD PhD, and Dr. Charles Nelson, PhD, at Boston Children’s Hospital are recruiting children ages 2-7 years with Fragile X syndrome to participate in a study of brain differences using non-invasive EEG.
Read moreNelson, Charles A.
Use of EEG as a Biomarker for Diagnosis and Outcomes in Neurodevelopmental Disorders
![Use of EEG as a Biomarker for Diagnosis and Outcomes in Neurodevelopmental Disorders](https://www.fraxa.org/wp-content/uploads/2020/10/Webinar-Graphic-EEG-as-a-Biomarker-no-date-720x300.png)
A series webinars focused on current topics in Fragile X research featuring Charles A. Nelson III, PhD, Professor at Harvard Medical School and Carol Wilkinson, MD, PhD, Instructor at Boston Children’s Hospital.
Read moreNeural Markers of Fragile X: A Powerful New Tool for Clinical Trials
![Neural Markers of Fragile X: A Powerful New Tool for Clinical Trials Neural Markers of Fragile X: A Powerful New Tool for Clinical Trials](https://www.fraxa.org/wp-content/uploads/2017/08/EEG-NeuralMarker-720x300.jpg)
Once the neural marker is identified for a particular challenge, such as kids with poor language versus good language, neural markers can be measured during drug and behavioral therapy trials to see if a child is improving based on objective biological measures.
Read more